ATE352310T1 - Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung - Google Patents

Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung

Info

Publication number
ATE352310T1
ATE352310T1 AT03010888T AT03010888T ATE352310T1 AT E352310 T1 ATE352310 T1 AT E352310T1 AT 03010888 T AT03010888 T AT 03010888T AT 03010888 T AT03010888 T AT 03010888T AT E352310 T1 ATE352310 T1 AT E352310T1
Authority
AT
Austria
Prior art keywords
zeolites
oral preparations
preparing oral
treating poisoning
poisoning
Prior art date
Application number
AT03010888T
Other languages
English (en)
Inventor
Mauro Fanelli
Original Assignee
Geomedical S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geomedical S R L filed Critical Geomedical S R L
Application granted granted Critical
Publication of ATE352310T1 publication Critical patent/ATE352310T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03010888T 2002-06-07 2003-05-15 Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung ATE352310T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001246A ITMI20021246A1 (it) 2002-06-07 2002-06-07 Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico

Publications (1)

Publication Number Publication Date
ATE352310T1 true ATE352310T1 (de) 2007-02-15

Family

ID=29434443

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03010888T ATE352310T1 (de) 2002-06-07 2003-05-15 Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung

Country Status (7)

Country Link
US (1) US20030228377A1 (de)
EP (1) EP1369121B1 (de)
AT (1) ATE352310T1 (de)
DE (1) DE60311351T2 (de)
ES (1) ES2280645T3 (de)
IT (1) ITMI20021246A1 (de)
PT (1) PT1369121E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
AU2004285450B2 (en) * 2003-10-20 2010-01-14 Gregory K. Frykman Zeolite molecular sieves for the removal of toxins
DE102005053090A1 (de) * 2005-11-04 2007-05-10 Hubert Danz Verwendung eines aktivierten Zeolithen als pharmazeutisches Mittel für die Reduzierung giftiger Stoffe
EP2358642B2 (de) 2008-11-21 2022-12-07 Froximun AG Klinoptilolith oder klinoptilolithhaltige gemische
US20100173016A1 (en) * 2009-01-08 2010-07-08 Reynolds Paul J Compositions and methods for the absorption, chelation, and elimination of trace metals
IT1396424B1 (it) * 2009-06-05 2012-11-23 Hf Europ Srl Prodotti alimentari comprendenti zeoliti
IT1403586B1 (it) * 2010-12-02 2013-10-31 Hf Europ Srl Nuovo uso di composizioni e di prodotti alimentari comprendenti ossidi e/o idrossidi
SI2673237T2 (sl) 2011-02-11 2025-12-31 Zs Pharma, Inc Uporaba cirkonijevega silikata v zdravljenju hiperkalemije
US9943637B2 (en) 2012-06-11 2018-04-17 ZS Pharma, Inc. Microporous zirconium silicate and its method of production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4627972A (en) * 1984-11-16 1986-12-09 Union Carbide Corporation Effervescent dentifrice
HU206484B (en) * 1989-03-24 1992-11-30 Orszagos Frederic Joliot Curie Silicium-containing environment-protecting composition adsorbing radioactive metal-isotopes and toxic heavy metals and process for producing pharmaceutical compositions containing this active component
EP0759290B1 (de) * 1995-08-14 1997-11-12 GEOMEDICAL S.r.l. Topische wässrige Gele oder Suspension auf Basis von pulverisiertem Vulkanischen oder diagenischem Minerale

Also Published As

Publication number Publication date
EP1369121B1 (de) 2007-01-24
PT1369121E (pt) 2007-04-30
US20030228377A1 (en) 2003-12-11
ES2280645T3 (es) 2007-09-16
DE60311351D1 (de) 2007-03-15
ITMI20021246A1 (it) 2003-12-09
EP1369121A1 (de) 2003-12-10
DE60311351T2 (de) 2007-05-24

Similar Documents

Publication Publication Date Title
ATE286500T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ATE309797T1 (de) Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen
DE60126947D1 (de) Behandlung der glykogenspeicherkrankheit typ ii
GB9813540D0 (en) Chemical compounds
DE602004001857D1 (de) Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
TW200514772A (en) Novel tetrahydropyridine derivatives
ATE527261T1 (de) 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten
YU24402A (sh) 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ATE352310T1 (de) Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung
DE60024857D1 (de) Neue verbindungen
ATE292117T1 (de) Zusammensetzungen zur behandlung von hautkrankheiten
IL148874A0 (en) Sulfonyl amino acid derivatives, their preparation and pharmaceutical compositions containing them
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
ATE422892T1 (de) Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle
ATE313541T1 (de) Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe
ATE386525T1 (de) 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel
Huang et al. Prevention of the epoxy resin-based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants
BR0110077A (pt) Compostos e composições antipicornavirais, seus usos farmacêuticos, e materiais para a sua sìntese
ATE3552T1 (de) Verfahren zur herstellung von phosphono-hydroxy- essigsaeure und salzen derselben sowie diese enthaltende autivirale mittel.
EP0913396A3 (de) Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1369121

Country of ref document: EP

REN Ceased due to non-payment of the annual fee